本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aclaris Therapeutics

1.64
+0.03001.86%
盘后1.61-0.0300-1.83%16:24 EDT
成交量:120.78万
成交额:201.14万
市值:1.78亿
市盈率:-1.13
高:1.78
开:1.62
低:1.61
收:1.61
数据加载中...
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/05/07

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

重要事件披露

Current report, items 1.01, 2.03, 3.02, 7.01, and 9.01
2020/03/13

重要事件披露

Current report, items 1.01 and 9.01
2020/03/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/06

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/25

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals